Starsource Multitrade Ltd vs CIPLA LTD
A side-by-side comparison of Starsource Multitrade Ltd (CHEMOPHARMALABORATORIESLTD) and CIPLA LTD (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, CIPLA LTD leads CHEMOPHARMALABORATORIESLTD vs CIPLA on 8 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation13
- Profitability22
- Growth· not comparable—
- Size & financial health13
Valuation
CIPLA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
CIPLA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free."]
- − ["Stock is trading at 9.40 times its book value", "Company has low interest coverage ratio.", "Promoter holding is low: 27.9%", "Company has a low return on equity of -31.6% over last 3 years.", "Company has high debtors of 337 days."]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
- − ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.